OM
TCON
Opaleye Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,764,508
| Closed | -$848K | – | 53 |
|
|
2023
Q3 | $848K | Hold |
4,764,508
| – | – | 0.28% | 36 |
|
|
2023
Q2 | $1.39M | Hold |
4,764,508
| – | – | 0.33% | 40 |
|
|
2023
Q1 | $9M | Buy |
4,764,508
+174,508
| +4% | +$330K | 2.7% | 8 |
|
|
2022
Q4 | $6.84M | Buy |
4,590,000
+400,000
| +10% | +$596K | 2.38% | 12 |
|
|
2022
Q3 | $7M | Buy |
4,190,000
+64,678
| +2% | +$108K | 2.89% | 10 |
|
|
2022
Q2 | $8.25M | Buy |
4,125,322
+970,224
| +31% | +$1.94M | 3.72% | 8 |
|
|
2022
Q1 | $8.3M | Buy |
3,155,098
+100,098
| +3% | +$263K | 2.58% | 14 |
|
|
2021
Q4 | $8.46M | Buy |
3,055,000
+536,629
| +21% | +$1.49M | 1.79% | 21 |
|
|
2021
Q3 | $9.75M | Hold |
2,518,371
| – | – | 1.82% | 17 |
|
|
2021
Q2 | $16.3M | Hold |
2,518,371
| – | – | 2.71% | 10 |
|
|
2021
Q1 | $20.7M | Hold |
2,518,371
| – | – | 3.04% | 8 |
|
|
2020
Q4 | $29.5M | Buy |
2,518,371
+504,933
| +25% | +$5.91M | 3.85% | 7 |
|
|
2020
Q3 | $10.4M | Buy |
+2,013,438
| New | +$10.4M | 2.04% | 19 |
|
|
2015
Q2 | – | Sell |
-12,172
| Closed | -$171K | – | 50 |
|
|
2015
Q1 | $171K | Buy |
+12,172
| New | +$171K | 0.08% | 37 |
|